AUSTINLAZ · Healthcare
AUSTINLAZ
Non-operating Establishments · Current price ₦3.73
Market cap
₦4.03B
P/E ratio
N/A
P/B ratio
2.94x
Dividend yield
N/A
Smaller cap profile, so timing and volatility matter more.
Compare
Compare Nigerian stocks before you decide.
Put a few Nigerian stocks side by side and see the differences faster.
Comparison board
Side-by-side stock view
Selected stocks
2/2
Free plan compares up to 2 names
Average dividend yield
N/A
Quick income lens across the current set
Cheapest P/E
NEIMETH
40.5x earnings
Decision summary
Line up a few names and make the differences obvious.
AUSTINLAZ looks strongest overall right now. Value leans toward NEIMETH, while income support looks better on either side.
Build compare set
Pick the names you want to judge side by side.
Compare should feel like a shortlist conversation, not a spreadsheet. Start with the names you are actually considering right now.
What to watch
Look for one clear winner on value, one on income, and one on stability before you decide.
A stock can be good and still be the wrong pick for your current goal. Compare makes that obvious faster.
Pro unlocks 4-stock compare boards and more AI compare depth when the shortlist gets tighter.
Compare slot 1
NEIMETH · Healthcare
NEIMETH
Pharmaceutical Preparations · Current price ₦9.25
Market cap
₦39.5B
P/E ratio
40.5x
P/B ratio
15.04x
Dividend yield
N/A
Smaller cap profile, so timing and volatility matter more.
AUSTINLAZ · Healthcare
AUSTINLAZ
Non-operating Establishments · Current price ₦3.73
Market cap
₦4.03B
P/E ratio
N/A
P/B ratio
2.94x
Dividend yield
N/A
Smaller cap profile, so timing and volatility matter more.
NEIMETH · Healthcare
NEIMETH
Pharmaceutical Preparations · Current price ₦9.25
Market cap
₦39.5B
P/E ratio
40.5x
P/B ratio
15.04x
Dividend yield
N/A
Smaller cap profile, so timing and volatility matter more.
Comparison table
See the differences in one view.
| Metric | AUSTINLAZ | NEIMETH |
|---|---|---|
| Current price | ₦3.73 | ₦9.25 |
| Market cap | ₦4.03B | ₦39.5B |
| P/E ratio | N/A | 40.5x |
| P/B ratio | 2.94x | 15.04x |
| Dividend yield | N/A | N/A |